Overview

Study to Compare Different Formulations of AZD3355

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare different formulations of AZD3355 in regard to possible adverse events such as sensations of numbness, tinglings and heat in the skin.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Lesogaberan